Bariatric surgery and type 2 diabetes

JAAPA. 2020 Jan;33(1):28-32. doi: 10.1097/01.JAA.0000615484.77430.1b.

Abstract

Type 2 diabetes is primarily managed with lifestyle modifications, self-monitoring of blood glucose, and medication. The goal is to maintain A1C less than 7% in most patients and prevent damage to other organs such as the kidneys and heart. Patients who are obese and cannot achieve normal blood glucose levels despite diet, exercise, and multiple medications may be considered for bariatric surgery. The Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy have been shown to improve A1C, reduce weight, and reduce the number of medications patients need for diabetes management. Comorbidities such as hyperlipidemia and hypertension also may improve. This article describes types of bariatric surgery, proper selection of surgical candidates, patient education, and the postoperative patient management necessary for long-term success in improving blood glucose control.

Publication types

  • Review

MeSH terms

  • Avitaminosis / epidemiology
  • Avitaminosis / prevention & control
  • Avitaminosis / therapy
  • Bariatric Surgery*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism*
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemia / epidemiology
  • Hypoglycemia / prevention & control
  • Hypoglycemia / therapy
  • Hypoglycemic Agents / therapeutic use
  • Life Style
  • Malabsorption Syndromes / epidemiology
  • Malabsorption Syndromes / prevention & control
  • Malabsorption Syndromes / therapy
  • Obesity / complications
  • Obesity / metabolism
  • Obesity / surgery*
  • Patient Education as Topic
  • Patient Selection
  • Postoperative Care
  • Postoperative Complications / epidemiology
  • Postoperative Complications / prevention & control
  • Postoperative Complications / therapy
  • Weight Loss
  • Weight Reduction Programs

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • hemoglobin A1c protein, human